Article

Forbes on 2024-05-14 11:43

Ozempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study Finds

Researchers also found patients taking semaglutide could sustain weight loss of around 10% up to four years.

John Deanfield

Related news

Anti-obesity jab ‘cuts risk of heart attack or stroke regardless of weight lost’Shropshire Star
New Orleans , Venice
Ozempic found to cut heart disease and keep weight off for four years euronews
New England , Denmark , Venice , Houston
Weight loss jabs could 'cut risk of heart attack or stroke', new study claims The Daily Record
New Orleans , Venice , Scotland
BComing off Ozempic slowly could prevent weight gain, study shows bloomberg.com
Denmark , Italy , Venice , Tama-shi , Los Angeles
Ozempic cuts risk of chronic kidney disease complications, study finds The New York Times
Sydney , Michigan , New England , Stockholm , United States
Weight Loss Drugs Like Ozempic Boost Risk Of Serious Stomach Issues—But It’s Still Rare Forbes
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds Forbes
What is Ozempic? Why stars risk 'old face' for trendy weight-loss drug New York Post
Washington , New Jersey , Beverly Hills , Los Angeles , Wall Street
Ozempic drug found to reduce heart risk in overweight non-diabetics newatlas.com
Melbourne
People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds Seattle Times
Weight-Loss Drugs Ozempic and Wegovy Can Also Protect the Heart Wired.com
Europe , Sweden , Los Angeles , Kansas City , Saint Luke
Weight loss drug Wegovy cuts risk of heart problems, maker says Star Tribune
England
Weight-loss drug Wegovy approved by FDA to cut heart attack, stroke risk New York Post
Americas , Los Angeles
Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests Shropshire Star
Diabetics’ weight loss drug Ozempic draws demand, and questions Merced Sun-Star
DHow Ozempic, weight-loss drugs force health enthusiasts to change dcourier.com
The Street
Weight loss drugs: Fake Ozempic and Wegovy surge in Europe Politico.eu
Portugal , Spain , France , Italy , Belgium